• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

ABBV STOCK HITS RECORD ALL TIME HIGH

Quote




















anonymous said:
I could see 60 after ___ news breaks.
Click to expand...


NO WAY !!!! YOU ARE A NEGATIVE PERSON !! OUR COMPANY WILL TAKE OFF AND HIT $125-150 THIS SUMMER !!! THE PIPELINE IS OUTSTANDING AND OUR LEADER IS A STRATEGIC PLANNER OF WORLD CLASS CALIBER. HE IS RECOGNIZED IN PHARMA AS ONE OF THE BEST AND HAS NUMEROUS HONORARY PHD'S.
 




anonymous said:
NO WAY !!!! YOU ARE A NEGATIVE PERSON !! OUR COMPANY WILL TAKE OFF AND HIT $125-150 THIS SUMMER !!! THE PIPELINE IS OUTSTANDING AND OUR LEADER IS A STRATEGIC PLANNER OF WORLD CLASS CALIBER. HE IS RECOGNIZED IN PHARMA AS ONE OF THE BEST AND HAS NUMEROUS HONORARY PHD'S.
Click to expand...

Not only PHD's, but many Honorary GED's as well!
 




















anonymous said:
Not all bad. The May Dividend will buy more in reinvesting. Buckle up for a big second half of 2018.
Click to expand...

Just placed buy order for 750 shares, max 90. This may be the bargain of the year if I get it. This stock will be pushing 125 to 150 by 3Q18 per financial pro's in pharma. Cant believe more aren't doing this. You must be dumb as a brick to not buy in. Wish I had more cash to put in, but wife needs a new car.
 




anonymous said:
Just placed buy order for 750 shares, max 90. This may be the bargain of the year if I get it. This stock will be pushing 125 to 150 by 3Q18 per financial pro's in pharma. Cant believe more aren't doing this. You must be dumb as a brick to not buy in. Wish I had more cash to put in, but wife needs a new car.
Click to expand...

Baby needs a new pair of shoes.
 












The share buy back of $7.5 billion is a smoke screen to boost crumbling stock.
The Corporate Tax reform was not meant to let greedy CEOs like Rick to pull this BS move. Trump was an idiot giving these leechs a licence to steal.
 




Whoa, Vpak and Mavyret pulled in $919 million ? Looks like Jeff H. And Lootzie are getting the ball rolling. HCV is a small safety net for Abbvie, but nonetheless it's pulling in billions now.
 












Ricks lying again at earnings call ? $7.5 B going to stock buy back NOT the fairy tale spun below

Since that time, we've continued to contemplate the most effective ways to deploy our investment opportunities from tax reform to maximize the benefit and to support our business over the long term. Now with the benefit of tax reform, we expect to invest more aggressively in R&D, exploring opportunities to augment our early-stage pipeline and add additional R&D capabilities. In support of this, we plan to continue to expand our oncology presence in Northern California, with a focus on further driving R&D innovation.

We also plan to invest more heavily in support of numerous products we expect to launch over the next 18 months, ensuring that these new therapies are well-positioned to achieve their maximum commercial potential. All of these actions demonstrate that tax reform is having the intended impact, creating new jobs and helping to stimulate U.S. investment.
 




Top Bottom
Back
Quote